Patents by Inventor Boualem Sendid

Boualem Sendid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosing invasive infections
    Patent number: 9778259
    Abstract: The present invention concerns an in vitro method for diagnosing invasive candidiasis (IC) in a subject which comprises detecting the presence of a Candida glycan and detecting the presence of antibody directed against a protein selected from the group consisting of fructose bisphosphate aldolase (Fba1), enolase 1 (Eno1), heat shock protein 90 (Hsp90), hyphal wall protein (Hwp1), and mannoprotein 65 (Mp65) in a blood, plasma or serum sample of the subject. The invention also relates to a method of determining a suitable treatment regimen for a patient and to a kit for implanting the methods described herein.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: October 3, 2017
    Assignees: Bio-Rad Innovations, Centre Hospitalier Universitaire De Lille, Universite Lille 2 Droit et Sante
    Inventors: Sebastien Damiens, Chantal Fradin, Daniel Poulain, Boualem Sendid, Marc Charles Victor Tabouret
  • In vitro diagnostic method for an invasive fungal infection using MALDI-TOFF mass spectrometry
    Patent number: 9360470
    Abstract: A method for the in vitro diagnosis of an invasive fungal infection by MALDI-TOF mass spectrometry. The method involves, providing a liquid biological sample from a mammal, said biological sample containing, in particular, proteins and/or lipids and/or salts and/or polysaccharides and/or oligosaccharides and/or monosaccharides capable of forming complexes with said proteins and/or lipids and/or salts; treating said sample with biological liquid so as to extract said polysaccharides and/or oligosaccharides and/or monosaccharides; determining, by MALDI-TOF mass spectrometry, whether or not there is present among said extracted polysaccharides, oligosaccharides and/or monosaccharides, at least one given compound of interest coming from said fungal microorganism and chosen from polysaccharides, oligosaccharides and monosaccharides; and deducing, if said given compound of interest is present in said sample, that said mammal is suffering from an invasive fungal infection.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: June 7, 2016
    Assignees: Centre Hospitalier Regional Universitaire De Lille, Universite De Droit Et Sante De Lille, Universite Sciences Technologies Lille, Centre National De La Recherche Scientifique
    Inventors: Daniel Poulain, Boualem Sendid, Yann Guerardel, Nadine Francois
  • IN VITRO DIAGNOSTIC METHOD FOR AN INVASIVE FUNGAL INFECTION USING MALDI-TOFF MASS SPECTROMETRY
    Publication number: 20150338391
    Abstract: A method for the in vitro diagnosis of an invasive fungal infection by MALDI-TOF mass spectrometry. The method involves, providing a liquid biological sample from a mammal, said biological sample containing, in particular, proteins and/or lipids and/or salts and/or polysaccharides and/or oligosaccharides and/or monosaccharides capable of forming complexes with said proteins and/or lipids and/or salts; treating said sample with biological liquid so as to extract said polysaccharides and/or oligosaccharides and/or monosaccharides; determining, by MALDI-TOF mass spectrometry, whether or not there is present among said extracted polysaccharides, oligosaccharides and/or monosaccharides, at least one given compound of interest coming from said fungal microorganism and chosen from polysaccharides, oligosaccharides and monosaccharides; and deducing, if said given compound of interest is present in said sample, that said mammal is suffering from an invasive fungal infection.
    Type: Application
    Filed: June 24, 2013
    Publication date: November 26, 2015
    Inventors: Daniel POULAIN, Boualem SENDID, Yann GUERARDEL, Nadine FRANCOIS
  • METHOD FOR DIAGNOSING INVASIVE CANDIDA INFECTIONS
    Publication number: 20140004538
    Abstract: The present invention concerns an in vitro method for diagnosing invasive candidiasis (IC) in a subject which comprises detecting the presence of a Candida glycan and detecting the presence of antibody directed against a protein selected from the group consisting of fructose bisphosphate aldolase (Fba1), enolase 1 (Eno1), heat shock protein 90 (Hsp90), hyphal wall protein (Hwp1), and mannoprotein 65 (Mp65) in a blood, plasma or serum sample of the subject. The invention also relates to a method of determining a suitable treatment regimen for a patient and to a kit for implanting the methods described herein.
    Type: Application
    Filed: March 18, 2013
    Publication date: January 2, 2014
    Inventors: Sebastien DAMIENS, Chantal FRADIN, Daniel POULAIN, Boualem SENDID, Marc Charles Victor TABOURET
  • Synthetic oligomannosides, preparation and uses thereof
    Publication number: 20060270627
    Abstract: A pharmaceutical composition including a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis which is homologous to a wall oligomannoside of an infectious organism or pathogen, or a derivative thereof, and a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: August 1, 2006
    Publication date: November 30, 2006
    Applicant: Centre Hospitalier regional universitaire (CHRU)
    Inventors: Jacques Esnault, Pierre Sinay, Reynald Chevalier, Jean-Frederic Colombel, Jean-Maurice Mallet, Boualem Sendid, Thierry Jouault, Daniel Poulain, Pierre-Andre Trinel
  • Synthetic oligomannosides, preparation and uses thereof
    Patent number: 7109182
    Abstract: A pharmaceutical composition including a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis which is homologous to a wall oligomannoside of an infectious organism or pathogen, or a derivative thereof, and a pharmaceutically acceptable vehicle.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: September 19, 2006
    Assignee: Centre Hospitalier Regional Universitaire (CHRU)
    Inventors: Jacques Esnault, Pierre Sinay, Reynald Chevalier, Jean-Frédéric Colombel, Jean-Maurice Mallet, Boualem Sendid, Thierry Jouault, Daniel Poulain, Pierre-André Trinel
  • Synthetic oligomannosides, preparation and uses thereof
    Publication number: 20030105060
    Abstract: A pharmaceutical composition including a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis which is homologous to a wall oligomannoside of an infectious organism or pathogen, or a derivative thereof, and a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: May 23, 2002
    Publication date: June 5, 2003
    Applicant: Centre Hospitalier Regional Universitaire (CHRU)
    Inventors: Jacques Esnault, Pierre Sinay, Reynald Chevalier, Jean-Frederic Colombel, Jean-Maurice Mallet, Boualem Sendid, Thierry Jouault, Daniel Poulain, Pierre-Andre Trinel